UVS Hospitality and Services Limited has received regulatory approval to relocate its registered office from West Bengal to Maharashtra, marking a significant corporate restructuring development for the company.

Regulatory Approval Details

The company received the certified true copy of the order dated 20th January, 2026 from the Regional Director, Eastern Region, under Section 13(4) of the Companies Act, 2013. This approval authorizes the shifting of the registered office from the State of West Bengal to the State of Maharashtra.

Compliance and Disclosure

The company has informed BSE Limited about this development on 6th February, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was signed by Preeti Goyal, Company Secretary and Compliance Officer.

Company Background

UVS Hospitality and Services Limited was formerly known as Thirdwave Financial Intermediaries Ltd. The company currently maintains its registered office in Kolkata, West Bengal, and operates a corporate office in Mumbai, Maharashtra.

The approval enables the company to formalize its registered office relocation, which could streamline its operations given its existing corporate presence in Maharashtra.

UVS Hospitality and Services Limited has announced key leadership changes with the appointment of Mrs. Prathima Madineni as Managing Director for a five-year term. The Board of Directors approved the appointment during their meeting held on January 30, 2026, based on recommendations from the Nomination and Remuneration Committee.

Board Appointment Details

The company's Board of Directors has made two significant appointments for Mrs. Prathima Madineni (DIN: 06365444):

The company confirmed that Mrs. Madineni is not debarred from holding the office of director by virtue of any SEBI order or any other authority, in accordance with the stock exchange circular dated June 20, 2018.

Professional Background

Mrs. Prathima Madineni brings extensive pharmaceutical industry experience to her new role. Her professional profile highlights include:

• Over two decades of pharmaceutical marketing leadership experience
• Expertise in portfolio growth and strategic marketing initiatives
• Strong track record in team leadership and brand development
• Experience with differentiated brand go-to-market launches across leading Indian pharmaceutical companies
• Specialization in acute and sub-chronic therapies including dermatology, gynecology, gastrointestinal, pain management, and nutrition
• Proven ability to deliver revenue growth, market-share gains, and brand leadership
• Early adoption of social and digital platforms for patient engagement and physician activation

Regulatory Compliance

The appointment has been made in full compliance with the provisions of the Companies Act, 2013 and follows proper corporate governance protocols. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The appointment is subject to approval by the company's shareholders and represents a strategic move to strengthen the leadership team with experienced pharmaceutical industry expertise.